Levodopa, melanoma, and Parkinson's disease.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8469320.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Previous reports and the Physicians' Desk Reference caution against the use of levodopa in Parkinson's disease (PD) patients with melanoma. A critical review of the literature reveals only anecdotal evidence to support a link between levodopa and melanoma. In fact, levodopa has an antitumor effect on melanoma. We report nine patients with PD and melanoma who were treated with levodopa/carbidopa (L/C). Current evidence suggests that L/C can be used safely in PD patients with a history of melanoma.
Medical subject headings
- Antiparkinson Agents
- Levodopa
- Melanoma
- Neoplasm Recurrence, Local
- Parkinson Disease
- Skin Neoplasms